Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION BP
Report ID | 72011 |
Drug Identification Number | 02462338 |
Brand name | AMPICILLIN SODIUM FOR INJECTION BP |
Common or Proper name | Ampicillin |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | AMPICILLIN |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 15 mL Vial x10 |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-01-11 |
Estimated end date | |
Actual end date | 2019-01-13 |
Shortage status | Resolved |
Updated date | 2019-01-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-01-14 | French | Compare |
v4 | 2019-01-14 | English | Compare |
v3 | 2019-01-12 | English | Compare |
v2 | 2019-01-11 | French | Compare |
v1 | 2019-01-11 | English | Compare |
Showing 1 to 5 of 5